The present Invention provides moieties that bind to the asymmetric contact Interlace of a receptor tyrosine kinase (RTK), wherein the moieties Inhibit igand Induced trans autophosphorylation of the RTIC The present invention also provides methods of treating or preventing an RTK-associatsd disease and methods for identifying moieties that bind to an asymmetric contact Interface of an RTK.